SEC Company Response from ENDOCARE INC (CIK 0001003464) — Sep 26, 2005
ENDOCARE INC (CIK 0001003464)
Date: Sept. 26, 2005 · CIK: 0001003464 · Accession: 0000950137-05-011698
AI Filing Summary & Sentiment
File numbers found in text: 333-123866
Show Raw Text
CORRESP
1
filename1.htm
corresp
Endocare, Inc.
201 Technology Drive
Irvine, California 92618
September 26, 2005
Via Edgarlink and Facsimile
Securities and Exchange Commission
Division of Corporation Finance
Mail Stop 0306
100 F Street, N.E.
Washington, DC 20549
Attention: Mr. Tom Jones
Re:
Endocare, Inc.
Registration Statement on Form S-2 (File No. 333-123866)
Acceleration Request
Requested Date:
Wednesday, September 28, 2005
Requested Time:
3:00 p.m., Eastern Time
Ladies and Gentlemen:
Endocare, Inc. (the “Registrant”) hereby requests, in accordance with Rule 461 of the General
Rules and Regulations under the Securities Act of 1933, as amended, that the Commission take
appropriate action to make the Registrant’s Registration Statement on Form S-2 (File No.
333-123866) effective at the Requested Date and Requested Time as set forth above or as soon
thereafter as practicable. Please advise the undersigned and the persons indicated on the cover of
the Registration Statement when the order permitting such Registration Statement to become
effective is issued.
Very truly yours,
Endocare, Inc.
By:
/s/ Michael R. Rodriguez
Michael R. Rodriguez
Senior Vice President,
Finance and Chief Financial Officer